Sucralfate: From Basic Science to the Bedside

ISBN-13: 9781475770193 / Angielski / Miękka / 2013 / 366 str.

Daniel Hollander; Guido N. Tytgat; D. Hollander

Opis

International researchers summarize the current understanding of peptic disease and trace the development of a novel new drug for peptic disease therapy-sucralfate. Contributors present laboratory research along side data from clinical trials as well as from the practice of medicine. Articles discuss the history of sucralfate's development, mechanisms of action, clinical efficacy, and future directions for research. This volume will be of interest to scientists and clinicians working in gastroenterology and gastrointestinal physiology.

Spis treści

Introduction; D. Hollander, G.N.J. Tytgat. Pathophysiology of Peptic Ulcer Disease; F. Halter. Decreased Intragastric Acid Concentration as an Approach to Peptic Disease Therapy; A.B.R. Thomson. Strengthening of Mucosal Defenses as an Approach to Peptic Disease Therapy; A.S. Tarnawski. History of the Development of Sucralfate; A. Ishimori. The Chemistry of Sucralfate; K. Ochi. Binding of Bile Acids by Sucralfate; W.F. Caspary. Binding of Sucralfate to the Mucosal Surface; G. Morris. Stimulation of Mucus Production by Sucralfate; C. TasmanJones. Stimulation of Gastroduodenal Bicarbonate Secretion by Sucralfate; D.W. Rees. Effect of Sucrose Octasulphate on Isolated Gastric Cells; M. Lucey, T. Yamada. Effect of Sucralfate of Gastric Surfactant; B.A. Hills. Stimulation of Mucosal Prostaglandins by Sucralfate; D. Rachmilewitz. Effect of Sucralfate on Helicobacter Pylori; J.A. Louw. Sucralfate and Cell Proliferation; H. Kuwayama. Effect of Sucralfate on Vascular Factors: Mucosal Vasoprotection and Angiogenesis; S. Szabo. Sucralfate Effects on Growth Factor Availability; J. Konturek. 16 additional articles. Index.